Upload
Featured Recent Articles Topics Login Upload

Search Results for 'phase placebo'

phase placebo published presentations and documents on DocSlides.

Edward Fox, MD, PhD Phase 2 Multicenter Study Results of
Edward Fox, MD, PhD Phase 2 Multicenter Study Results of
by medmacr
Ublituximab. , a Novel Glycoengineered Anti-CD20 M...
Phase 2 Trial Evaluating the Effect of Dexpramipexole on Eosinophil Biomarkers and Lung Function in
Phase 2 Trial Evaluating the Effect of Dexpramipexole on Eosinophil Biomarkers and Lung Function in
by thomas
Professor Salman Siddiqui, Clinical Professor of A...
HIV Prevention England Conference
HIV Prevention England Conference
by felicity
18 February 2020. -. A two-stage randomised phase ...
References (1) Epidemiology
References (1) Epidemiology
by jordyn
1. Queiroz LP, Peres MF, Piovesan EJ et al. . A na...
Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i
Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i
by zen
knowledge. ). Incorporate evidence-based research ...
Results from a Phase 2 Randomized, Placebo-Controlled, Double Blind Study of the
Results from a Phase 2 Randomized, Placebo-Controlled, Double Blind Study of the
by ella
Hedgehog Pathway Antagonist IPI-926 . in Patients ...
Thalidomide: Thalidomide is a medical drug that caused 
Thalidomide: Thalidomide is a medical drug that caused 
by skylar
unexpected and serious damage.  to unborn babies ...
Deciding to Participate in Research
Deciding to Participate in Research
by jasmine
The Pros and Cons. Natalie Diaz, MD. Pacific Neuro...
The Northeast ALS Consortium
The Northeast ALS Consortium
by unita
Merit E. Cudkowicz, MD, MSc. Mass General Hospital...
Best of ASCO GU Session Sandy Srinivas.MD
Best of ASCO GU Session Sandy Srinivas.MD
by experimentgoogle
Stanford University. Outline. Abstract #4. :. . I...
Planning for Retirement: Depression
Planning for Retirement: Depression
by debby-jeon
Richard C. Shelton, M.D.. James G. Blakemore Rese...
Update on Treatment of Myasthenia Gravis
Update on Treatment of Myasthenia Gravis
by conchita-marotz
KUMC Neurology Grand Rounds. 07/29/2016. Richard...
Planning for Retirement: Depression
Planning for Retirement: Depression
by marina-yarberry
Richard C. Shelton, M.D.. James G. Blakemore Rese...
Phase II Clinical Trial Austin Goodrich and Laura Peterman
Phase II Clinical Trial Austin Goodrich and Laura Peterman
by della
Outline. Review of a phase I trial. What is a phas...
The Trust-TSC Phase 3 Clinical Trial for Seizures in TSC
The Trust-TSC Phase 3 Clinical Trial for Seizures in TSC
by willow
Mary Kay Koenig, MD. Associate Vice Chair for Clin...
End-Points and Rationale for Phase III Trials in HCC: Adjuvant, Intermediate, and Advanced HCC
End-Points and Rationale for Phase III Trials in HCC: Adjuvant, Intermediate, and Advanced HCC
by maniakti
Richard S. Finn, MD. Professor of Clinical Medicin...
(NYSE American: CANF) (TASE:CFBI)
(NYSE American: CANF) (TASE:CFBI)
by kampsta
Can - Fite Presentation September 2020 (NYSE Ameri...
Ezra W Cohen University of California, San Diego
Ezra W Cohen University of California, San Diego
by natalia-silvester
Ezra W Cohen University of California, San Diego...
Bruix J et al. Lancet 2017;389(10064):56-66.
Bruix J et al. Lancet 2017;389(10064):56-66.
by kittie-lecroy
Regorafenib. 160 mg/d. (n = 379). Placebo. (n = ...
My Experiences as an FDA Statistician
My Experiences as an FDA Statistician
by aaron
Yeh-Fong Chen, Ph.D. . FDA/CDER/OB/DB3. CBA 2016-...
OMICS
OMICS
by phoebe-click
International . welcomes submissions that are ori...
OMICS International welcomes submissions that are original and technically so as to serve both th
OMICS International welcomes submissions that are original and technically so as to serve both th
by briana-ranney
OMICS Journals are poised in excellence by publi...
A Phase 2 Trial of the Efficacy and Safety of Evinacumab in Patients with Severe Hypertriglyceridem
A Phase 2 Trial of the Efficacy and Safety of Evinacumab in Patients with Severe Hypertriglyceridem
by cohen386
Robert S. Rosenson,. 1. Daniel Gaudet,. 2. Chris...
August 28, 2022 NCT04304534
August 28, 2022 NCT04304534
by christina
John H. Alexander, MD, MHS. on behalf of the PACIF...
DEVELOPMENT OF RV3 ROTAVIRUS VACCINE
DEVELOPMENT OF RV3 ROTAVIRUS VACCINE
by williams
Mahendra. . Suhardono. Production Director. 11. t...
Copyright
Copyright
by mia
2021 Zacks Investment Research All Rights Reserved...
Management Presentation
Management Presentation
by ivy
1 1 January 2017 Jefferies 2017 London Healthcare ...
by billiontins
2018;36(8):773-9.. Nivolumab Monotherapy (Cohort 1...
by clustik
proceedings from the live CME event and may includ...
PrECOG 0102: A Randomized, Double-Blind Phase II Trial of Fulvestrant plus Everolimus or Placebo
PrECOG 0102: A Randomized, Double-Blind Phase II Trial of Fulvestrant plus Everolimus or Placebo
by tawny-fly
Post-Menopausal Women with Hormone-Receptor Posit...
Case Scenario #1 Luis is a 9-year-old male seen in clinic with a complaint of worsening pruritus causing difficulties in school and sleep.
Case Scenario #1 Luis is a 9-year-old male seen in clinic with a complaint of worsening pruritus causing difficulties in school and sleep.
by conchita-marotz
Case Scenario #1 Luis is a 9-year-old male seen i...
Jointly provided by & This activity is supported by educations grants from Novartis Pharmaceuticals Corporation, Pfizer, and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com
Jointly provided by & This activity is supported by educations grants from Novartis Pharmaceuticals Corporation, Pfizer, and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com
by olivia-moreira
Jointly provided by ...
ADVANCES IN THERAPY FOR SARCOMA AND GIST
ADVANCES IN THERAPY FOR SARCOMA AND GIST
by ellena-manuel
Angela . Cioffi. , MD. Sarcoma Research Program c...
What’s Next – and When:
What’s Next – and When:
by sherrill-nordquist
An Update on Injectable . P. revention. Alex R Ri...
BELLE-3: A Phase III Study of
BELLE-3: A Phase III Study of
by faustina-dinatale
Buparlisib. and . Fulvestrant. in Postmenopausa...
ART for Prevention… What Happens Next?
ART for Prevention… What Happens Next?
by briana-ranney
Myron S. Cohen, MD. Yeargan-Bate Eminent Professo...
Novel Biologic Therapies for
Novel Biologic Therapies for
by olivia-moreira
Second-Line Gastric Cancer. Charles S. Fuchs, MD....
Long Acting Injectable Agents for HIV Prevention
Long Acting Injectable Agents for HIV Prevention
by giovanna-bartolotta
Nyaradzo M Mgodi (. MBChB. , . MMed. ). On behalf...
Selecting Therapy for Relapsed/
Selecting Therapy for Relapsed/
by tawny-fly
Refractory Multiple Myeloma. Case #1. Monitoring ...
MultipleSclerosis:Current&Emerging
MultipleSclerosis:Current&Emerging
by yoshiko-marsland
Treatments Personalized Strategies. Dr. Suhail A...